VOYA Investment Management
DFTX

VOYA Investment Management’s Definium Therapeutics DFTX Stock Holding History

VOYA Investment Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$310K Buy
16,384
+392
+2% +$6.65K ﹤0.01% 1936
2025
Q4 		$214K Buy
15,992
+1,710
+12% +$21.2K ﹤0.01% 2121
2025
Q3 		$168K Sell
14,282
-6,979
-33% -$65.1K ﹤0.01% 2218
2025
Q2 		$138K Buy
21,261
+146
+0.7% +$960 ﹤0.01% 2411
2025
Q1 		$124K Sell
21,115
-2,551
-11% -$18.3K ﹤0.01% 2386
2024
Q4 		$165K Sell
23,666
-637
-3% -$4.38K ﹤0.01% 2446
2024
Q3 		$138K Buy
24,303
+95
+0.4% +$661 ﹤0.01% 2584
2024
Q2 		$175K Buy
+24,208
New +$212K ﹤0.01% 2510
2022
Q1 		– Sell
-8,971
Closed -$186K – 2719
2021
Q4 		$186K Buy
8,971
+12
+0.1% +$383 ﹤0.01% 2538
2021
Q3 		$313K Buy
8,959
+527
+6% +$22.8K ﹤0.01% 2321
2021
Q2 		$436K Buy
+8,432
New +$443K ﹤0.01% 2172

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VOYA Investment Management's DFTX Position: Q1 2026 in Review

VOYA Investment Management increased its Definium Therapeutics (DFTX) stake by 2.5% in Q1 2026, buying an estimated $6.65K and bringing the position to 16,384 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #1936.

VOYA Investment Management first reported a position in DFTX in Q2 2021 and has held it in 11 quarters since. The position peaked at $436K in Q2 2021. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • VOYA Investment Management held 16,384 shares of Definium Therapeutics worth $310K as of Q1 2026.
  • VOYA Investment Management bought 392 Definium Therapeutics shares in Q1 2026, an estimated $6.65K.
  • Definium Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1936 holding.
  • VOYA Investment Management first reported a position in Definium Therapeutics in Q2 2021 and has held it in 11 quarters since.
  • VOYA Investment Management's Definium Therapeutics position peaked at $436K in Q2 2021.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.